The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment Data-Reference-Cited by-同舟云学术

The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment Data

Published:2017 Issue:6 Volume:47 Page:888
ISSN:1738-5520
Container-title:Korean Circulation Journal
language:en
Short-container-title:Korean Circ J

Author:

Kim Choongki¹,Shin Dong-Ho¹²,Ahn Chul-Min¹²,Kim Jung-Sun¹²,Kim Byeong-Keuk¹²,Ko Young-Guk¹²,Choi Donghoon¹²,Hong Myeong-Ki¹²³,Park Juhee⁴,Lee Hyeyeong⁴,Choi Yoon Jung⁴,Choi Youn Song⁴,Oh Sang-Kwon⁴,Jang Yangsoo¹²³

Affiliation:

1. Division of Cardiology, Department of Internal Medicine, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul, Korea.

2. Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul, Korea.

3. Severance Biomedical Science Institute, Yonsei University College of Medicine, Seoul, Korea.

4. Health Insurance Review and Assessment Service, Wonju, Korea.

Publisher

The Korean Society of Cardiology

Subject

Cardiology and Cardiovascular Medicine,Internal Medicine

Link

https://synapse.koreamed.org/pdf/10.4070/kcj.2017.0072

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potent P2Y<sub>12</sub> Inhibitor Monotherapy for Acute Coronary Syndrome;Circulation Journal;2023-11-07

2. Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndrome and on Dialysis: A Meta-Analysis;Cureus;2023-06-10

3. Real-world evidence of switching P2Y12 receptor–inhibiting therapies to prasugrel after PCI in patients with ACS: results from EFF-K registry;BMC Cardiovascular Disorders;2023-01-09

4. The Optimal Duration and De-escalation Strategy of Antiplatelet Agents and Anticoagulation Agents in Korean Patients Undergoing Percutaneous Coronary Intervention;CardioMetabolic Syndrome Journal;2023

5. A randomised comparison of coronary stents according to short or prolonged durations of dual antiplatelet therapy in patients with acute coronary syndromes: a pre-specified analysis of the SMART-DATE trial;EuroIntervention;2021-08